Krishna Institute of Medical Sciences · NSE: KIMS · BSE: 543308
Q2 FY24 results · Jul–Sep 2023
Krishna Institute of Medical Sciences reported revenue from operations of ₹652.48 crore (up 15.7% from Q2 FY23) and net profit of ₹101.29 crore (down 4.5% from Q2 FY23) for Q2 FY24 (Jul–Sep 2023), on a consolidated basis.
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 652.48 | 564.07 | +15.7% | 606.03 | +7.7% |
| Other income | 2.88 | 9.20 | −68.7% | 3.11 | −7.4% |
| Total income | 655.36 | 573.28 | +14.3% | 609.14 | +7.6% |
| Profit before tax | 138.62 | 137.47 | +0.8% | 118.58 | +16.9% |
| Net profit for the period | 101.29 | 106.07 | −4.5% | 86.67 | +16.9% |
| Attributable to shareholders of the company | 92.18 | 97.11 | −5.1% | 80.81 | +14.1% |
| EPS, basic (₹) | 11.50 | 12.14 | −5.3% | 10.10 | +13.9% |
| Net margin (%) | 15.5 | 18.8 | 14.3 |
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 316.25 | 292.21 | +8.2% | 298.90 | +5.8% |
| Other income | 3.57 | 7.63 | −53.3% | 3.84 | −7.1% |
| Total income | 319.81 | 299.84 | +6.7% | 302.74 | +5.6% |
| Profit before tax | 89.02 | 83.78 | +6.2% | 83.98 | +6.0% |
| Net profit for the period | 66.16 | 61.20 | +8.1% | 62.63 | +5.6% |
| EPS, basic (₹) | 8.27 | 7.65 | +8.1% | 7.83 | +5.6% |
| Net margin (%) | 20.9 | 20.9 | 21.0 |
Consolidated
- Filed with BSE
- 09 Nov 2023, 15:32 IST
- Board meeting
- 07 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 09 Nov 2023, 15:32 IST
- Board meeting
- 07 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE